US trial of noninvasive ALS device gets green light to enroll patients
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling patients in the U.S.| ALS News Today
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling patients in the U.S.| ALS News Today
Marisa Wexler is a senior science writer for ALS News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
